A new study by a team of Harvard-led researchers contradicts a widely held theory that major transitions in evolution always happened in big, quick (geologically speaking) bursts, triggered by major environmental shifts.
A new study of ice-core data shows that an unusual, six-year period of cold temperatures and heavy rainfall coincided with European deaths during the 1918 Spanish flu.
Harvard has digitized 19th-century glass models of 15 marine invertebrates made by Rudolf and Leopold Blaschka. The 3D models are the result of between 250 to 700 images that had to be taken per glass piece.
Data science provides a foundation for an important front in the battle against COVID-19. The Harvard Data Science Review, a journal of the Harvard Data Science Initiative, is helping keep data scientists connected and up to date on the latest findings.
A team of undergrads is using computational biology to create a therapeutic that enables the body to quickly develop COVID-19 antibodies and jump-start the immune system’s battle against the disease.
Researchers led by Christian Rutz, 2019–2020 Grass Fellow at the Radcliffe Institute for Advanced Study, are examining human impact on wildlife using data collected during the pandemic quarantine.
Researchers have developed a synthetic lining that could deliver drugs in a sustained way to the small intestine, offering hope for those suffering from lactose intolerance, diabetes, and obesity.
In a collaboration between Harvard and Sony, engineers have brought surgical robotics down to the microscale by creating a new, origami-inspired miniature manipulator to improve precision and control.
The seductive powers, dark history, health benefits, and harmful side effects of the world’s most-used drug, are included in Michael Pollan’s new audiobook, “Caffeine: How Coffee and Tea Created the Modern World.”
A biomaterials-based infection vaccine strategy shows first promise in eliciting immunity against SARS-CoV-2 and could be applied broadly to stave off infectious disease.
The Wyss Institute made improvements to its face shields based on recommendations from area hospitals. Joining forces with a Mansfield, Mass.-based manufacturer, the institute’s face shields are now being produced at a rate of 400,000 a day.
Harvard University researchers have identified a unique characteristic of the resistant cancer cells, which could lead to an inhibitor can be repurposed and combined with chemotherapy to improve patient outcomes.
Emily Balskus has won the Alan T. Waterman Award, the National Science Foundation’s most prestigious prize for scientists under 40 in the United States.